Espira Investments

Hendlův dvůr
U Matěje 24/5
160 00 Praha 6
+420 222 263 815
www.espirainvestments.com

Contact
Emília Mamajová
Partner
emilia@espirainvestments.com
Information about the company
Volume of Funds Managedunder 30 million EUR
Type of InvestmentGrowth financing, financing and support for acquisitions, support for ownership and capital restructuring, management buyout
Preferred Ammount of InvestmentEUR 1-3 mil.
Sectore Preferences
Geographical FocusCEE – Central and Eastern Europe with a focus on CZ & SK
Number of Deals in CZXXX
Current Portfolio in CZXXX
Current Portfolio out of CZXXX

Lighthouse Ventures

Address
Palác Adria
Jungmannova 36/31
11000, Praha 1
Czech Republic
www.lhv.vc
Contact

Michal Zálešák

Managing Partner

michal@lhv.vc

Information about the company
Volume of Funds Managed23,8 milionů EUR
Type of Investmentpre-seed, seed, startup financing
Preferred Ammount of Investment20 tisíc – 1 milion EUR
Sectore PreferencesTechnologie, B2B SaaS
Geographical FocusCzech Republic
Number of Deals in CZ23
Current Portfolio in CZPekat, Spaceti, Wereldo, Supersoused, AhoyTeam, NG Aviation, Searpent, UptimAI, Strafos, Persoo, Nulisec, Lyopor, Distro, Kooperace.cz, Foxdeli, Financial Antivirus, Localazy, Cytokine, Investown, DaySwaps
Current Portfolio out of CZXXX

i&i Biotech Investments

Address

Jugoslávských partyzánů 1426/7
160 00 Praha 6
+420 725 731 199
www.inibio.eu
info@inibio.eu

Contact
Tomáš Maršálek
CFO
tomas.marsalek@inibio.eu
Information about the company
The i&i Biotech Fund (i&i Bio) is an investment fund that has met the exacting criteria of the European Investment Fund (EIF) to become one of the more than 500 funds supported by the EIF. The fund was established with substantial involvement from i&i Prague, which in addition to financial backing will also be providing unique knowhow and expertise. The goal is to build on the results and experience of i&i Prague and increase the value of the fund’s assets by investing primarily in Czech and European biotechnology spinoffs. The fund makes significant contributions to the development and commercialization of original and quality projects in the areas of biotechnology and the natural sciences, namely those producing novel drugs, diagnostic methods, and medical devices.

Abris Capital

Address
ul. Grzybowska 5a
Grzybowska Park
00-132 Warsaw
Poland
www.abris-capital.com
Contact
Renáta Ďurčová
r.durcova@abris-capital.com
Information about the company
Volume of Funds ManagedEUR 502 mil (Abris Fund III), EUR 450 mil (Abris Fund II)
Type of InvestmentGrowth and buyout acquisitions – management buyouts (MBO & MBI), expansion financing, industry consolidation
Preferred Ammount of InvestmentEUR 30-70m
Sectore Preferences
Geographical FocusCEE – Central and Eastern Europe
Number of Deals in CZ1
Current Portfolio in CZAAA Auto
Current Portfolio out of CZXXX

ARX Equity Partners

Address
28. října 12
110 00 Prague 1
+420 224 235 399
www.arxequity.com
Contact
Michal Aron
Partner
aron@arxequity.com
Information about the company
Volume of Funds Managed EUR 200 million
Type of Investment acquisitions, management buyout (MBO & MBI), expansion capital, sector consolidation
Preferred Ammount of Investment EUR 5 – 50 million (total transaction)
Sectore Preferences
Geographical Focus Central Europe
Number of Deals in CZ 14
Current Portfolio in CZ Wieden, TES Vsetín, Promens Zlín
Current Portfolio out of CZ TMX Mobile Solutions, Instrumentation Technologies

CEE Equity Partners

Address
Purkyňova 74/2
110 00 Praha 1
www.cee-equity.com
Contact
Tomáš Čása
Partner
t.casa@cee-equity.com
Information about the company
Volume of Funds Managed 
Type of InvestmentCEE Equity Partners Ltd is the investment advisor for the two China-CEE Funds with committed funds of over $1.2 billion. The Funds were established by China Exim Bank in partnership with other institutional investors from the CEE region to capitalize on investment opportunities in CEE countries. The objective of the Funds is to identify and partner with dynamic businesses and together contribute to the vibrant growth of the CEE economies whilst providing good returns to the investors
Preferred Ammount of Investment 
Sector Preferences_
Geographical Focus 
Number of Deals in CZ 
Current Portfolio in CZ 
Current Portfolio out of CZXXX

Credo Ventures

Address
Karlovo Náměstí 10
120 00 Prague 2
+420 211 153 211
www.credoventures.com
Contact
Vladislav Jež
Partner
jez@credoventures.com
Information about the company
Volume of Funds ManagedEUR 170 million
Type of Investmentstart-up, growth capital, expansion capital
Preferred Ammount of Investment50k EUR – 10M EUR
Sector PreferencesIT & internet, mobile communication,
Geographical FocusCEE
Number of Deals in CZ15
Current Portfolio in CZAngee, Cera, Codasip, Comprimato, Deepnote, Gamee, GoodVision, IP Fabric, LIV, Manta, Price f(x), productboard, Runecast, Spaceflow, Supernova, TeskaLabs, VersionPress
Current Portfolio out of CZXXX

Enterprise Investors

Address
590 Madison Avenue, 21st floor
NY 10022 USA
+420 731 627 132
+420 257 315 631
+420 234 656 138
www.ei.com.pl/cz
Contact
Vjačeslav Lypko
Investment Director
vjaceslav.lypko@ei.com.pl
Information about the company
Volume of Funds Managed over EUR 2.5 billion
Type of Investment acquisition, buyout (MBO & MBI), expansion capital, sector consolidation
Preferred Ammount of Investment PEF VII: EUR 20-50 million PEF VIII: EUR 20-75 million
Sectore Preferences
Geographical Focus CEE
Number of Deals in CZ 2 (including regional investments)
Current Portfolio in CZ 0 (including regional investments)
Current Portfolio out of CZ 16

Genesis Capital Equity s.r.o.

Address
Na Šafránce 22
101 00 Prague 10
+420 271 740 207
www.genesis.cz
Contact
Tatiana Balkovicová
Senior Investment Director (Genesis Private Equity Fund)
balkovicova@genesis.cz

Jiří Beneš
Partner (Genesis Growth Equity Fund)
benes@genesis.cz

Information about the company
Volume of Funds ManagedEUR 200 million
Type of Investmentbuyout, sector consolidation, growth capital
Preferred Ammount of InvestmentEUR 1-12 million (equity ticket)
Sectore Preferences
Geographical FocusCzech Republic, Slovakia, Poland, Hungary and Austria
Number of Deals in CZQuinta Analytica, HP Tronic / Datart, D2G, Sanborn, CN Group, Conectart, GTH catering, R2B2, Home Care Promedica
  
Current Portfolio out of CZStangl Technik, 11 Entertainment, Summa Linguae Technologies

EUR 1-12 million (equity ticket)